SANA
Sana Biotechnology Inc
NASDAQ: SANA · HEALTHCARE · BIOTECHNOLOGY
$3.29
+1.23% today
Updated 2026-04-30
Market cap
$877.47M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.96
Dividend yield
—
52W range
$2 – $7
Volume
3.1M
Sana Biotechnology Inc (SANA) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-13.49M | $-85.50M | $-137.98M | $-251.05M | $-290.05M | $-253.58M | $-223.15M | $-143.83M |
| Capital expenditures | $460000.00 | $26.18M | $23.87M | $29.86M | $20.88M | $20.03M | $33.43M | $938000.00 |
| Depreciation | — | — | — | — | — | — | — | — |
| Stock-based comp | $118000.00 | $1.50M | $5.83M | $22.36M | $38.34M | $35.53M | $37.68M | $25.46M |
| Free cash flow | $-13.96M | $-111.69M | $-161.85M | $-280.92M | $-310.93M | $-273.61M | $-256.58M | $-144.77M |
| Investing cash flow | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $134.90M | $-74.58M | — | — | — |